secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2026-06-04T21:01:23+00:00
Accession:  0001493152-26-027307
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lixte Biotechnology closes ~$16.6M registered direct offering of common stock and warrants
--------------------------------------------------------------------------------

- Gross proceeds of ~$16.6 million from sale of 2,625,362 shares and pre-funded warrants.
- Offering priced at $6.31 per common share and $6.3099 per pre-funded warrant.
- Pre-funded warrants exercisable immediately at $0.0001 per share.
- Net proceeds to be used for general corporate purposes and working capital.
- Offering closed on June 4, 2026 under existing shelf registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315226027307/0001493152-26-027307-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315226027307/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-027307

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer